Pharmacology of amineptine, an antidepressant agent acting on the dopaminergic system: A review

International Clinical Psychopharmacology

Volumn 12, Issue SUPPL.3, 1997, Pages

  Garattini, Silvio ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Amineptine; Antidepressants; Dopamine uptake; Noradrenaline uptake; Receptor downregulation

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; ALPHA 2 ADRENERGIC RECEPTOR; AMINEPTINE; BETA ADRENERGIC RECEPTOR; DESIPRAMINE; DEXAMPHETAMINE; DEXFENFLURAMINE; DOPAMINE; DOPAMINE 2 RECEPTOR; HOMOVANILLIC ACID; NOMIFENSINE; NORADRENALIN; TRICYCLIC ANTIDEPRESSANT AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE UPTAKE; DOPAMINERGIC SYSTEM; FRONTAL CORTEX; IN VITRO STUDY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MICRODIALYSIS; NONHUMAN; NUCLEUS ACCUMBENS; POTENTIOMETRY; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION; SHORT SURVEY;

EID: 0030881199     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-199707003-00003     Document Type: Short Survey

References (27)

1. Billion A, Kamal S, Grivois J (1979) Ambulatory treatment of depressed states in a general hospital setting and in private practice. Vol Thér Entretiens Bichat 117-122.
2. Bonnet JJ, Chagraoui A, Protais P, et al. (1987) Interactions of amineptine with the neuronal dopamine uptake system: neurochemical in vitro and in vivo studies. J Neural Transm 69:211-220.
3. Bornstein S (1979) Cross-over trial comparing the antidepressant effects of amineptine and maprotiline. Curr Med Res Opin 6:107-110.
4. Borsini F, Bendotti C, Velkov V, et al. (1981) Immobility test: effects of 5-hydroxytryptaminergic drugs and role of catecholamines in the activity of some antidepressants. J Pharm Pharmacol 33:33-37.
5. Borsini F, Pulvirenti L, Samanin R (1985) Evidence of dopamine involvement in the effect of repeated treatment with various antidepressants in the behavioural 'despair' tests in rats. Eur J Pharmacol 110:253-256.
6. Carboni E, Tanda GL, Frau R, et al. (1990) Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals. J Neurochem 55:1067-1070.
7. Ceci A, Garattini S, Gobbi M, et al. (1986) Effect of long-term amineptine treatment on pre- and postsynaptic mechanisms in rat brain. Br J Pharmacol 88:269-275.
8. Dalery J, Rochat C, Peyron E, et al. (1992) Comparative study of the efficacy and acceptability of amineptine and fluoxetine in patients with major depression. Encephale 18:257-262.
9. De Simoni MG, Dal Toso G, Algeri S, et al. (1986) Differences in the effect of the antidepressant amineptine on striatal and limbic DOPAC measured by HPLC-ECD and in vivo voltammetry. Eur J Pharmacol 123:433-439.
10. Deniker P, Besancon G, Colonna L, et al. (1982) Extensive multicentric study of 1354 cases of depressed subjects treated with amineptine [in French]. Encephale 8:355-370.
11. Grislain L, Gele P, Bromet N, et al. (1990) Metabolism of amineptine in rat, dog and man. Eur J Drug Metab Pharmacokinet 15:339-345.
12. Invernizzi R, Pozzi L, Vallebuona F, et al. (1992) Effect of amineptine on regional extracellular concentrations of dopamine and noradrenaline in the rat brain. J Pharmacol Exp Ther 262:769-774.
13. 1C receptors in antiserotonergic properties of some antidepressant drugs. Eur J Pharmacol 231:223-229.
14. Kemali D (1989) A multicenter Italian study of amineptine (Survector 100). Clin Neuropharmacol 12 (suppl 2):S41-S50.
15. Narahashi T (1974) Chemicals as tools in the study of excitable membranes. Physiol Rev 54:814-869.
16. Poignant JC (1979) Pharmacological review on amineptine [in French]. Encephale 5:709-720.
17. Poignant JC, Avril A (1978) Pharmacological studies on drugs acting on the social behaviour of the squirrel monkey. Arzneimittelforschung 28:267-271.
18. Ponzio F, Achilli G, Perego C, et al. (1981) Differential effects of certain dopaminergic drugs on the striatal concentration of dopamine metabolites, with special reference to 3-methoxytyramine. Neurosci Lett 27:61-67.
19. Ponzio F, Achilli G, Garattini S, et al. (1986) Amineptine: its effect on the dopaminergic system of rats. J Pharm Pharmacol 38:301-303.
20. Rampello L, Nicoletti G, Raffaele R (1991) Dopaminergic hypothesis for retarded depression: a symptom profile for predicting therapeutical responses. Acta Psychiatr Scand 84:552-554.
21. Riche C, Lachatre G, Guedes Y, et al. (1989) Pharmacokinetics of amineptine after single-dose, repeated treatment and study of the at-risk populations. Clin Neuropharmacol 12 (suppl 2):S32-S40.
22. Samanin R, Bernasconi S, Garattini S (1975) The effect of nomifensine on depletion of brain serotonin and catecholamines induced respectively by fenfluramine and 6-hydroxydopamine in rats. Eur J Pharmacol 34:377-380.
23. Samanin R, Jori A, Bernasconi S, et al. (1977) Biochemical and pharmacological studies on amineptine (S 1694) and (+)-amphetamine in the rat. J Pharm Pharmacol 29:555-558.
24. Sbarra C, Negrini P, Fanelli R (1979) Quantitative analysis of amineptine (S-1694) in biological samples by gas chromatography-mass fragmentography. J Chromatogr 162:31-38.
25. Sbarra C, Castelli MG, Noseda A, et al. (1981) Pharmacokinetics of amineptine in man. Eur J Drug Metab Pharmacokinet 6:123-126.
26. Tsaconas C, Padieu P, d'Athis P, et al. (1989) Gas chromatographic-mass spectrometric assessment of the pharmacokinetics of amineptine and its main metabolite in volunteers with liver impairment. J Chromatogr 487:313-329.
27. Vassout A, Bruinink A, Krauss J, et al. (1993) Regulation of dopamine receptors by bupropion: comparison with antidepressants and CNS stimulants. J Recept Res 13:341-354.